🇺🇸 Lederfolin in United States

408 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Neutropenia — 60 reports (14.71%)
  2. Thrombocytopenia — 54 reports (13.24%)
  3. Pyrexia — 50 reports (12.25%)
  4. Anaemia — 41 reports (10.05%)
  5. Diarrhoea — 41 reports (10.05%)
  6. Off Label Use — 37 reports (9.07%)
  7. Vomiting — 34 reports (8.33%)
  8. Paraesthesia — 32 reports (7.84%)
  9. Asthenia — 30 reports (7.35%)
  10. Infusion Related Reaction — 29 reports (7.11%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Lederfolin approved in United States?

Lederfolin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Lederfolin in United States?

University of Pisa is the originator. The local marketing authorisation holder may differ — check the official source linked above.